Clinical Trial Update: DEB-TACE for Hepatocellular Carcinoma [NA]

View source ↗

Summary

A clinical trial investigating drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Surefire Medical, Inc. | Conditions: Hepatocellular Carcinoma | NA | Status: TERMINATED